Join us for the 2nd VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology
We are delighted to invite you to the second edition of the VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology, a first-class event bringing together leading national and international experts in the field.
Organized by the Vall d’Hebron Institute of Oncology (VHIO) with the support of the BBVA Foundation, this symposium will provide a cutting-edge assessment of current advancements, as well as an insightful look into the future of cell-based therapies in oncology.
We look forward to welcoming you to Barcelona for an inspiring event!
We are delighted to invite you to the second edition of the VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology, a first-class event bringing together leading national and international experts in the field.
Organized by the Vall d’Hebron Institute of Oncology (VHIO) with the support of the BBVA Foundation, this symposium will provide a cutting-edge assessment of current advancements, as well as an insightful look into the future of cell-based therapies in oncology.
We look forward to welcoming you to Barcelona for an inspiring event!
Information
Date: November 13-14, 2025
Location: Recinte Modernista de Sant Pau (Sant Pau Art Nouveau Site), Barcelona, Spain.
Target Audience: This symposium is designed for scientists, researchers, clinicians, patient representatives, and students interested in the latest breakthroughs in cell-based cancer therapies.
Stay tuned for updates. In the meantime, subscribe to our mailing list to receive the latest news about the symposium.
The 1st VHIO-BBVA Foundation International Symposium on Cell-Based Therapies in Oncology, organized by Dr. Alena Gros (VHIO) and Dr. Sonia Guedan (IDIBAPS), took place on November 29-30, 2023. The event brought together 100 scientists, clinicians, and researchers to discuss advancements in cell-based therapies.
Location: Recinte Modernista de Sant Pau (Sant Pau Art Nouveau Site), Barcelona, Spain.
Target Audience: This symposium is designed for scientists, researchers, clinicians, patient representatives, and students interested in the latest breakthroughs in cell-based cancer therapies.
Program & Speakers
Our Scientific Committee is curating an outstanding program. This edition will again address a variety of topics including determinants of ACT activity, adoptive cell therapies in solid cancers and pediatric malignancies, early clinical development in cell therapies, advances in CAR T cells for hematological malignancies and other indications, next-generation CAR T cells, and more!Stay tuned for updates. In the meantime, subscribe to our mailing list to receive the latest news about the symposium.
Highlights from the 1st edition
The 1st VHIO-BBVA Foundation International Symposium on Cell-Based Therapies in Oncology, organized by Dr. Alena Gros (VHIO) and Dr. Sonia Guedan (IDIBAPS), took place on November 29-30, 2023. The event brought together 100 scientists, clinicians, and researchers to discuss advancements in cell-based therapies.
The Vall d’Hebron Institute of Oncology (VHIO), a reference center for personalized medicine in oncology, was created in 2006. Thanks to its pioneering multidisciplinary and translational research model and its participation in consortia and projects with other prestigious centers worldwide, it has positioned itself as one of Europe's most important comprehensive centers. VHIO is capable of transforming, in record time, the latest research discoveries in the laboratory in early clinical trials and, therefore, in new opportunities for cancer patients, including cell therapies.
The BBVA Foundation promotes knowledge through research, artistic endeavors, and cultural creations. In collaboration with VHIO, the Foundation established the pioneering Comprehensive Program of Cancer Immunotherapy & Immunology (CAIMI) in 2017. This program has significantly improved VHIO's research in Immuno-Oncology, as well as advanced the development of cell therapies. As a result of this valuable support, we are delighted to present the inaugural symposium, which aims to disseminate high-quality research findings and foster collaboration among international experts to advance our understanding of cancer.
